Unregulated or overexpressed matrix metalloproteinases (MMPs), includi
ng stromelysin, collagenase, and gelatinase, have been implicated in s
everal pathological conditions including arthritis and cancer. Small-m
olecule MMP inhibitors may have therapeutic value in the treatment of
these diseases. In this regard, the solution structures of two stromel
ysin/inhibitor complexes have been investigated using H-1, C-13, and N
-15 NMR spectroscopy. Both inhibitors are members of a novel class of
matrix metalloproteinase inhibitor that contain a thiadiazole soup and
that interact with stromelysin in a manner distinct from other classe
s of inhibitors. The inhibitors coordinate the catalytic zinc atom thr
ough their exocyclic sulfur atom, with the remainder of the ligand ext
ending into the S-1-S-3 side of the active site. The binding of inhibi
tor containing a protonated or fluorinated aromatic ring was investiga
ted using H-1 and F-19 NMR spectroscopy. The fluorinated ring was foun
d to have a reduced ring-flip rate compared to the protonated version.
A strong, coplanar interaction between the fluorinated ring of the in
hibitor and the aromatic ring of Tyr155 is proposed to account for the
reduced ring-flip rate and for the increase in binding affinity obser
ved for the fluorinated inhibitor compared to the protonated inhibitor
. Binding interactions observed for the thiadiazole class of Ligands h
ave implications for the design of matrix metalloproteinase inhibitors
.